-
21
Platinum drugs upregulate CXCR4 and PD‐L1 expression via ROS‐dependent pathways, with implications for novel combined treatment in gastric cancer
Published 2025-01-01Subjects: Get full text
Article -
22
DRG2 as a Biomarker to Enhance the Predictive Efficacy of PD-L1 Immunohistochemistry Assays
Published 2024-12-01Subjects: Get full text
Article -
23
Enhanced effect of radiofrequency ablation on HCC by siRNA-PD-L1-endostatin Co-expression plasmid delivered
Published 2025-03-01Subjects: Get full text
Article -
24
Clinical characteristics, diagnosis, treatment, and prognosis of Atezolizumab-induced encephalitis, aseptic meningitis or meningoencephalitis
Published 2025-01-01Subjects: Get full text
Article -
25
Neoadjuvant chemoradiotherapy up-regulates PD-L1 in radioresistant colorectal cancer
Published 2025-03-01Subjects: Get full text
Article -
26
Discovery of novel biphenyl compounds bearing hydroxamic acid moiety as the first PD-L1/class I HDACs dual inhibitors
Published 2025-12-01Subjects: “…PD-1/PD-L1…”
Get full text
Article -
27
Regulation of adipocyte differentiation and lipid metabolism by novel synthetic chromenes exploring anti-obesity and broader therapeutic potential
Published 2025-02-01Subjects: Get full text
Article -
28
Feasibility of Endobronchial Ultrasound Guided Miniforceps Biopsy for PD‐L1 Expression and Quantitative Tissue Analysis
Published 2025-01-01Subjects: Get full text
Article -
29
Exploring the Acquisition of Progressive Forms in Albanian ESL Learners (The Acquisition of Progressive Forms in Albanian ESL Learners)
Published 2024-12-01Subjects: Get full text
Article -
30
Stemness-related gene signatures as a predictive tool for breast cancer radiosensitivity
Published 2025-01-01Subjects: Get full text
Article -
31
Teacher target language input and young learners’ aural comprehension of English
Published 2021-10-01Subjects: Get full text
Article -
32
Chitinase-3-like-1: a multifaceted player in neuroinflammation and degenerative pathologies with therapeutic implications
Published 2025-01-01Subjects: “…CHI3L1…”
Get full text
Article -
33
ErbB- and MUC1-targeted CAR-T cell immunotherapy of oral squamous cell carcinoma
Published 2023-03-01Subjects: Get full text
Article -
34
Resetting the Hsc70-mediated lysosomal degradation of PD-L1 via a supramolecular meso peptide for the restoration of acquired anti-tumor T cell immunity
Published 2025-02-01Subjects: “…Cellular abundance of PD-L1…”
Get full text
Article -
35
Why PD-L1 expression varies between studies of lung cancer: results from a Bayesian meta-analysis
Published 2025-02-01Subjects: “…PD-L1…”
Get full text
Article -
36
Infiltration of CD8+ cytotoxic T-cells and expression of PD-1 and PD-L1 in ovarian clear cell carcinoma
Published 2025-02-01Subjects: Get full text
Article -
37
Mealworm-Derived Protein Hydrolysates Enhance Adipogenic Differentiation via Mitotic Clonal Expansion in 3T3-L1 Cells
Published 2025-01-01Subjects: Get full text
Article -
38
Inosine enhances the efficacy of immune‐checkpoint inhibitors in advanced solid tumors: A randomized, controlled, Phase 2 study
Published 2024-09-01Subjects: Get full text
Article -
39
Extraction, GC-MS analysis, cytotoxic, anti-inflammatory and anticancer potential of Cannabis sativa female flower; in vitro, in vivo and in silico
Published 2025-02-01Subjects: Get full text
Article -
40
Structural analysis of light chain-driven bispecific antibodies targeting CD47 and PD-L1
Published 2024-12-01Subjects: Get full text
Article